Your Messages Inbox
Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. 2008 Exclusive Survey—Earnings: Good news for primary care income 3. Medicare pay-for-reporting effort draws fire from frustrated doctors 4. Debunking Myths in the US Healthcare System 5. Statins and cancer risk
Your Article Summary
See Latest ArticlesAPP Pharmaceutical Supports New USP Standards for Unfractionated Heparin
American Pharmaceutical Partners, 10/02/09
APP Pharmaceuticals, Inc., a wholly owned subsidiary of Fresenius Kabi Pharmaceuticals Holding, Inc., and the leading supplier of heparin sodium to the U.S. market, announced its continued support of the US Food & Drug Administration and medical community for the October 2009 implementation of the new United States Pharmacopeia monograph change for unfractionated heparin. The purpose of the USP monograph changes are to further assure the purity of the Active Pharmaceutical Ingredient through specific assay tests and calibrate activity to align with the International Standard issued by the World Health Organization.
Today in Drug Approvals...keeping you current
Receive free subspecialty "5-minute updates" via email
FDA Advisory Committee Supports Use of Aztreonam for Inhalation Solution for Patients with Cystic Fibrosis
Gilead, 12/14/09
Vigabatrin: a comprehensive review of drug properties including clinical updates following recent FDA approval
Expert Opinion in Pharmacotherapy, 12/09/09
Synthon announces European approvals for Raloxifene
Synthon, 12/08/09
Sponsor
Article Search
Sponsor
Sponsor